IBDEI2M1 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43809,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,43810,0)
 ;;=L29.9^^200^2217^251
 ;;^UTILITY(U,$J,358.3,43810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43810,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,43810,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,43810,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,43811,0)
 ;;=L30.0^^200^2217^232
 ;;^UTILITY(U,$J,358.3,43811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43811,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,43811,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,43811,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,43812,0)
 ;;=L30.1^^200^2217^140
 ;;^UTILITY(U,$J,358.3,43812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43812,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,43812,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,43812,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,43813,0)
 ;;=L30.2^^200^2217^132
 ;;^UTILITY(U,$J,358.3,43813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43813,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,43813,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,43813,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,43814,0)
 ;;=L30.4^^200^2217^144
 ;;^UTILITY(U,$J,358.3,43814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43814,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,43814,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,43814,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,43815,0)
 ;;=L30.8^^200^2217^135
 ;;^UTILITY(U,$J,358.3,43815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43815,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,43815,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,43815,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,43816,0)
 ;;=L30.9^^200^2217^136
 ;;^UTILITY(U,$J,358.3,43816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43816,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,43816,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,43816,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,43817,0)
 ;;=L40.0^^200^2217^253
 ;;^UTILITY(U,$J,358.3,43817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43817,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,43817,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,43817,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,43818,0)
 ;;=L40.1^^200^2217^256
 ;;^UTILITY(U,$J,358.3,43818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43818,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,43818,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,43818,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,43819,0)
 ;;=L40.2^^200^2217^11
 ;;^UTILITY(U,$J,358.3,43819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43819,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,43819,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,43819,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,43820,0)
 ;;=L40.3^^200^2217^255
 ;;^UTILITY(U,$J,358.3,43820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43820,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,43820,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,43820,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,43821,0)
 ;;=L40.4^^200^2217^157
 ;;^UTILITY(U,$J,358.3,43821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43821,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,43821,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,43821,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,43822,0)
 ;;=L40.8^^200^2217^252
 ;;^UTILITY(U,$J,358.3,43822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43822,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,43822,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,43822,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,43823,0)
 ;;=L40.9^^200^2217^254
 ;;^UTILITY(U,$J,358.3,43823,1,0)
 ;;=^358.31IA^4^2
